Great butterbur

Star

Petasites japonicus

Not yet clinically reviewed

Family: Asteraceae Genus: Petasites Species: japonicus

Synonyms: Nardosmia japonica

Great butterbur
Great butterbur

Traditionally used for

  • Cough & breathing

Cautions & contraindications

  • Pregnancy
  • Breastfeeding
  • Young children
  • Liver conditions
Moderate evidence · 6 studies

Western Herbalism Properties

Actions:
antispasmodicexpectorant

Botanical Description

Petasites japonicus, commonly known as fuki, giant butterbur, or Japanese butterbur, is a robust herbaceous perennial in the family Asteraceae native to East Asia, occurring in Japan, Korea, China, and the Russian Far East along moist streamsides, marsh edges, and damp deciduous forests. The plant arises from a stout, creeping rhizome that produces extensive clonal colonies. Flowering precedes leaf emergence: in early spring, dense clusters of pale yellow-white to greenish disc-flower heads appear at ground level on thick scapes 10 to 25 centimetres tall, surrounded by overlapping pale bracts. The leaves then expand to enormous, round to reniform blades up to 80 centimetres across on stout, fleshy petioles that may reach 1 to 2 metres in cultivated forms, with shallowly toothed or undulate margins, deep green above and lighter beneath. Achenes are linear and bear long silky pappus bristles. It spreads vigorously and is widely cultivated in Japan as the vegetable fuki.

Native Region: China North-Central, China South-Central, China Southeast, Japan, Korea, Kuril Is., Nansei-shoto, Primorye, Sakhalin

Active Constituents

Petasitenine (fukinotoxin)

Otonecine-type macrocyclic pyrrolizidine alkaloid

Concentration: Isolated from the young flower stalk, which is the part eaten in Japan as fuki-no-tou and the part historically substituted for Kuan Dong Hua; also recovered from the whole plant

A proven hepatocarcinogen, not a theoretical hazard. ACI rats given a 0.05 percent solution in drinking water all died or were killed moribund within 72 days with hepatic necrosis, haemorrhage and marked bile duct proliferation. At 0.01 percent, 8 of 10 rats surviving beyond 160 days developed liver tumours: haemangioendothelial sarcomas in 5 and liver cell adenomas in 5, two animals with both. No control animal developed a tumour. Like other 1,2-unsaturated pyrrolizidine alkaloids it is bioactivated in the liver to pyrrolic esters that alkylate DNA and sinusoidal endothelium, the mechanism of hepatic sinusoidal obstruction syndrome.

Neopetasitenine

Otonecine-type macrocyclic pyrrolizidine alkaloid

Concentration: Isolated from the whole plant alongside petasitenine and senkirkine

The acetylated congener of petasitenine. It belongs to the same 1,2-unsaturated class that carries the hepatotoxic and genotoxic liability of the group, and is hydrolysed toward petasitenine.

Senkirkine

Otonecine-type macrocyclic pyrrolizidine alkaloid

Concentration: Isolated from the whole plant; also the principal pyrrolizidine alkaloid of Tussilago farfara

Notable for being shared with coltsfoot, Tussilago farfara, the source of the pharmacopoeial drug Kuan Dong Hua for which this plant's flower buds have historically been substituted. A patient given the wrong one of these two drugs is not protected by the substitution: both carry senkirkine, and this plant carries petasitenine as well.

Secopetasitenine

Otonecine-type pyrrolizidine alkaloid

Concentration: A new alkaloid described from the whole plant in 2019, structurally derived from petasitenine

Its description in 2019 makes the point that the alkaloid inventory of this plant is still being added to. Any statement about the total pyrrolizidine burden of a sample is limited by which alkaloids the assay was set up to look for, and new members of the series are still being found.

Petasin

Eremophilane sesquiterpene ester (angeloyl ester)

Concentration: Quantified as the compound accounting for most of the anti-adipogenic activity of flower bud extract

The principal non-alkaloid active of the genus. In 3T3-F442A preadipocytes it suppressed differentiation with an IC50 of 0.95 micromolar and reduced PPAR-gamma, C/EBP-alpha and aP2 expression. The activity is structurally specific: isopetasin and petasol, its close analogues, did not reproduce it, which the authors attribute to the C11-C12 double bond and the angeloyl ester. Petasin is also the compound to which the antispasmodic and leukotriene-inhibiting effects of butterbur extracts are attributed.

Isopetasin

Eremophilane sesquiterpene ester

Concentration: A major sesquiterpene of the genus, present alongside petasin; the ratio of the two varies with chemotype and with storage

Included partly as a negative result: in the anti-adipogenic screen it was inactive where petasin was potent. The petasin to isopetasin ratio is used as a chemotype and quality marker across Petasites, and a product's activity cannot be inferred from total sesquiterpene content alone.

S-Petasin

Sulfur-containing eremophilane sesquiterpene ester

Concentration: First isolated from Petasites japonicus in 2019, having previously been known from Petasites hybridus, Petasites officinalis and Petasites formosanus

Inhibited adipogenesis in 3T3-L1 preadipocytes, reduced glucose uptake and triglyceride accumulation, and downregulated PPAR-gamma and its target genes dose-dependently. Its late discovery in this species is a good illustration of how much of the butterbur literature was generated in Petasites hybridus and only later checked in Petasites japonicus.

Bakkenolide B

Bakkanolide sesquiterpene lactone (spiro-lactone)

Concentration: Described as a major component of the leaves

Concentration-dependently inhibited antigen-induced degranulation of RBL-2H3 mast cells measured by beta-hexosaminidase release, suppressed induction of inducible nitric oxide synthase and cyclooxygenase 2 in mouse peritoneal macrophages, and in an ovalbumin asthma model strongly reduced eosinophil, macrophage and lymphocyte accumulation in bronchoalveolar lavage fluid. This is the best-supported anti-allergic constituent of the leaf, in mice.

Petasitesin A and petasitesin B

Aryltetralin lactone lignan

Concentration: Two new lignans isolated from a hot water extract of the leaves in 2019

Petasitesin A significantly inhibited both prostaglandin E2 and nitric oxide production in RAW264.7 macrophages and suppressed inducible nitric oxide synthase and cyclooxygenase 2 expression. Because they were isolated from a hot water extract they are constituents that a decoction actually delivers, which is not true of every compound reported from this plant.

Cimicifugic acid D

Phenolic acid ester (hydroxycinnamoyl ester)

Concentration: A known compound co-isolated from the hot water leaf extract

Inhibited prostaglandin E2 and nitric oxide production in RAW264.7 macrophages with potency comparable to petasitesin A. Its name reflects its first description in Cimicifuga; it is a good example of a phenolic marker shared across unrelated Asteraceae and Ranunculaceae drugs and therefore of no use for identity confirmation.

Flavonoid aglycones (quercetin and kaempferol)

Flavonol

Concentration: Reported among the antioxidant constituents of the plant

Ordinary dietary flavonols, responsible for a large part of the antioxidant capacity measured in this plant in vitro. They are not distinctive to the species and they are not what makes it either useful or dangerous.

⚠ Drug Interactions

Any hepatotoxic drug, and any patient with liver disease, portal hypertension or a haematopoietic stem cell transplant

Major Evidence: Established

This plant contains 1,2-unsaturated pyrrolizidine alkaloids of the otonecine type, including petasitenine, neopetasitenine, senkirkine and secopetasitenine. Petasitenine is a demonstrated hepatocarcinogen: in ACI rats a 0.01 percent drinking-water exposure produced liver haemangioendothelial sarcomas and hepatocellular adenomas in 8 of 10 animals surviving past 160 days, with none in controls, and a 0.05 percent exposure killed every animal within 72 days with hepatic necrosis and bile duct proliferation. Alkaloids of this class are bioactivated by hepatic cytochrome P450, principally CYP3A4, to pyrrolic esters that alkylate sinusoidal endothelial cells and DNA. The consequences are dose-cumulative and irreversible, and the European Union now sets maximum levels for the sum of 21 pyrrolizidine alkaloids in herbal infusions and food supplements, introduced by Commission Regulation (EU) 2020/2040 with effect from July 2022 and now carried in Regulation (EU) 2023/915. There is no established safe chronic intake of 1,2-unsaturated pyrrolizidine alkaloids.

Clinical note: Do not prescribe unstandardised whole-herb Petasites japonicus for continuous use, and do not use it at all in liver disease, in anyone on methotrexate, azole antifungals, isoniazid, high-dose paracetamol or amiodarone, or around a stem cell transplant where sinusoidal obstruction syndrome is already a risk. If a patient has been taking it, check ALT, AST, bilirubin and platelets, and ask specifically about right upper quadrant pain, weight gain and ascites.

Pregnancy, breastfeeding, and infants

Major Evidence: Established

1,2-Unsaturated pyrrolizidine alkaloids cross the placenta and are excreted in breast milk, and the fetal and neonatal liver is more vulnerable to them than the adult liver. This is a well-characterised property of the alkaloid class rather than an inference from this species, and it applies to the alkaloids this plant is documented to contain. It is the reason regulators set the tightest pyrrolizidine alkaloid limits on products aimed at infants and pregnant women.

Clinical note: Absolute avoidance in pregnancy and lactation, and never in a child. This includes the culinary use of the plant, which in Japan and Korea is a normal food.

Kuan Dong Hua (Farfarae Flos, Tussilago farfara) supplied as, or replaced by, the flower buds of this plant

Major Evidence: Established

Chinese herbal textual research on Kuan Dong Hua records that the flower buds of Petasites japonicus were used as Kuan Dong Hua in some periods, although the mainstream source through the dynasties was Tussilago farfara. The two share vernacular names in Chinese, including Dong Hua and Kuan Dong. The substitution is not a harmless one in either direction. Tussilago farfara carries senkirkine and senecionine; Petasites japonicus carries senkirkine as well, plus petasitenine, the alkaloid shown to be hepatocarcinogenic in rats. Worse, the Chinese quality convention for the flower drug prefers large unopened buds collected before flowering, which is the stage at which pyrrolizidine alkaloid content is highest, and petasitenine was originally isolated from precisely that material, the young flower stalk.

Clinical note: Confirm the botanical source of any Kuan Dong Hua by binomial, not by appearance or by Chinese name. Where a formula calls for Kuan Dong Hua and the supply cannot be traced to Tussilago farfara, substitute a different antitussive rather than accept an unidentified Asteraceae flower bud.

Petasites hybridus extracts (Petadolex, Ze 339) and the clinical evidence attached to them

Major Evidence: Established

Every controlled human trial in the butterbur literature used Petasites hybridus, not this species. The migraine prophylaxis evidence, including the systematic review of Petasites hybridus preparations, is for a specific carbon-dioxide extract of Petasites hybridus rhizome standardised on petasins and depleted of pyrrolizidine alkaloids. The allergic rhinitis evidence is for Ze 339, a supercritical carbon-dioxide leaf extract of Petasites hybridus. Neither product is Petasites japonicus, and neither is the crude herb of any species. A systematic search of the clinical literature finds no randomised or controlled human trial of Petasites japonicus at all: the only prospective clinical trial of this species is a veterinary phase 1 and 2 study in dogs. Transferring the Petasites hybridus results to this plant transfers an efficacy claim without transferring the alkaloid depletion step that makes those products tolerably safe.

Clinical note: If the clinical aim is migraine prophylaxis or allergic rhinitis on the strength of the butterbur trials, prescribe the studied Petasites hybridus extract, not this herb. Do not cite a Petasites hybridus trial in support of Petasites japonicus.

Paracetamol, ibuprofen and triptans taken alongside butterbur preparations

Moderate Evidence: Possible

Spontaneous reports of herb-induced liver injury with the Petasites hybridus extract Petadolex were reviewed in 2019. Most cases showed mild serum biochemistry changes, cases were rare and idiosyncratic, and they were frequently confounded by co-medication, since the population taking a migraine prophylactic is also taking analgesics and triptans. Human hepatocyte work in the same study found transaminase and cytochrome P450 monooxygenase changes when petasins were combined with therapeutic concentrations of ibuprofen, paracetamol and naratriptan. Separately, the only prospective trial of a Petasites japonicus preparation, a dose-escalation study in dogs, reported grade 1 alanine aminotransferase elevation.

Clinical note: Where any butterbur preparation is used for headache, agree the acute analgesic plan explicitly rather than leaving it to the patient, and check liver enzymes at baseline and again at four to six weeks.

Fuki eaten as a vegetable without the traditional Japanese pre-treatment

Moderate Evidence: Probable

The petioles and young flower spikes of this plant are a normal seasonal food in Japan and Korea, and the traditional preparation, boiling and prolonged soaking, is not merely for bitterness. Cooking pre-treatment of the petioles and young spikes has been shown to reduce their pyrrolizidine alkaloid content. Raw or lightly cooked material, and infusions made from the plant where the alkaloids stay in the liquid rather than being discarded with the soaking water, deliver much more alkaloid than the traditional dish does.

Clinical note: If a patient eats fuki, ask whether it is prepared traditionally with boiling and soaking and the water discarded. Advise against raw preparations, against making a tea from the plant, and against frequent consumption regardless of preparation.

Evidence Tier

Moderate evidence · 6 studies

Recorded studies by study design, strongest design at the top. This is a study-design tier only, not a GRADE rating: it does not weigh risk of bias, consistency or precision.

Verified: design read from PubMed for a DOI that resolves to the cited paper Unverified: taken from the study's recorded description

Clinical Studies

Carcinogenic Activity of Petasitenine, a New Pyrrolizidine Alkaloid Isolated From Petasites japonicus Maxim.

Hirono I, Mori H, Yamada K, Hirata Y, Haga M (1977) Journal of the National Cancer Institute animal Verified: In vitro / animal

The definitive carcinogenicity study for this plant's principal alkaloid. Petasitenine, isolated from the young flower stalk of Petasites japonicus, was given to ACI rats in drinking water. At 0.05 percent every animal died or was killed moribund within 72 days with hepatic necrosis, haemorrhage and marked bile duct proliferation. At 0.01 percent, 8 of 10 rats surviving beyond 160 days developed liver tumours, haemangioendothelial sarcomas in 5 and liver cell adenomas in 5, with 2 animals developing both. No control rat developed a liver tumour.

Single and Repeated Oral Dose Toxicity and Genotoxicity of the Leaves of Butterbur

Park S, Lim J, Lee KT, Oh MS, Jang DS (2021) Foods animal

A regulatory toxicity package on KP-1, a hot water extract of Petasites japonicus leaves, and the counterweight to the petasitenine data. Single-dose and two-week repeat-dose studies in rats showed no toxicologically significant clinical, haematological, biochemical or organ weight changes. At thirteen weeks, gastric hyperkeratosis and squamous hyperplasia of the limiting ridge appeared, giving a no observed adverse effect level of 1250 mg/kg/day, or 5000 mg/kg/day if the limiting ridge changes are discounted as rat-specific. Bacterial reverse mutation, chromosomal aberration in Chinese hamster lung cells and in vivo micronucleus tests were negative. This tests a specific hot water leaf extract, not the flower stalk and not the whole plant, and the two studies are not in conflict: what the extract contains is the question.

Clinical impact of butterbur shoot extract in dogs with oral melanoma: a combined phase 1 and 2 clinical trial

Noguchi S, Furuya M, Honda K, Ito R, Akao Y (2026) BMC Veterinary Research animal Verified: In vitro / animal

The only prospective clinical trial of a Petasites japonicus preparation in any species, and it is veterinary. Nine client-owned dogs received escalating oral doses of Japanese butterbur shoot extract from 50 to 200 mg/kg after radiotherapy or surgery; grade 1 alanine aminotransferase elevation and diarrhoea each occurred, and 200 mg/kg was taken forward. Sixteen dogs with stage 3 oral melanoma then received that dose; overall survival was significantly longer than historical controls but progression-free survival was not, and no dose-limiting toxicity occurred. Read it for what it is: a small single-arm study against historical controls, in dogs, with a liver enzyme signal.

Anti-allergic and anti-inflammatory effects of bakkenolide B isolated from Petasites japonicus leaves

Lee KP, Kang S, Park SJ, Choi YW, Lee YG, Im DS (2013) Journal of Ethnopharmacology animal Verified: In vitro / animal

Bakkenolide B, a major leaf sesquiterpene, concentration-dependently inhibited antigen-induced degranulation of RBL-2H3 mast cells, suppressed inducible nitric oxide synthase and cyclooxygenase 2 induction in mouse peritoneal macrophages, and in an ovalbumin-induced asthma model markedly reduced eosinophil, macrophage and lymphocyte accumulation in bronchoalveolar lavage fluid. Mouse and cell-line work; the human allergic rhinitis trials that this is often read alongside were done with Petasites hybridus, not this species.

Petasin is the main component responsible for the anti-adipogenic effect of Petasites japonicus

Uesugi S, Hakozaki M, Kanno Y, Shiraishi A, Suzuki M, Kimura KI, Shiono Y, Yano A (2022) Fitoterapia in vitro Verified: In vitro / animal

Screening flower bud extract in 3T3-F442A preadipocytes, petasin was quantified as the compound responsible for most of the anti-adipogenic activity, with an IC50 of 0.95 micromolar and suppression of PPAR-gamma, C/EBP-alpha and aP2. Isopetasin and petasol were inactive, locating the activity in the C11-C12 double bond and the angeloyl ester. Cell culture only, and the source material is the flower bud, the part with the highest pyrrolizidine alkaloid burden.

Chemical Constituents of the Leaves of Butterbur (Petasites japonicus) and Their Anti-Inflammatory Effects

Lee JS, Jeong M, Park S, Ryu SM, Lee J, Song Z, Guo Y, Choi JH, Lee D, Jang DS (2019) Biomolecules in vitro Verified: In vitro / animal

Two new aryltetralin lactone lignans, petasitesin A and petasitesin B, were isolated from a hot water extract of the leaves with six known compounds. Petasitesin A and cimicifugic acid D significantly inhibited prostaglandin E2 and nitric oxide production in RAW264.7 macrophages, and petasitesin A suppressed inducible nitric oxide synthase and cyclooxygenase 2 expression. Macrophage cell line only.

Historical Texts

Jiangxi Cao Yao (Jiangxi Herbal Medicines), entry Feng Dou Cai

Modern Chinese provincial herbal, 1970
The source text usually cited for the Chinese drug. Gives the actions as resolving toxin and dispelling stasis, for tonsillitis, abscesses and toxic sores, and venomous snakebite. The drug is defined as the rhizome and whole herb, harvested in summer and autumn. There is no entry for this plant in the Han, Tang, Song or Ming materia medica under its own name: as a Chinese drug it is a twentieth-century regional record, not a classical one.

Zhejiang Min Jian Chang Yong Cao Yao (Commonly Used Folk Herbs of Zhejiang)

Modern Chinese provincial herbal, 1960s to 1970s
Gives the actions as reducing swelling and stopping pain, resolving toxin and dispelling stasis, for traumatic injury and venomous snakebite. Records the local practice of pounding the fresh root and applying it around a snakebite wound. Nature and flavour are given as bitter and acrid, cool, at 9 to 15 g in decoction.

Herbal textual research on Farfarae Flos (Kuan Dong Hua) in classical formulas, China Journal of Experimental Traditional Medical Formulae

Modern textual scholarship, 2024, reviewing sources from the Han dynasty onward
Establishes that the mainstream botanical source of Kuan Dong Hua through the dynasties was Tussilago farfara, while recording that the flower buds of Petasites japonicus were also used as Kuan Dong Hua in some periods. This is the documentary basis for treating the two as a substitution pair rather than as separate drugs that never meet.

Japanese and Korean food and folk use of fuki

Continuous documented food use, Edo period to the present
The petioles and the young flower stalks, fuki and fuki-no-tou, are a normal seasonal vegetable, and the roots and stems have been used for migraine, tension headache and spasm in Japan and Korea. The traditional preparation always involves boiling and prolonged soaking with the water discarded, which is nominally for bitterness but has been shown to reduce the pyrrolizidine alkaloid content of the petioles and young spikes. A long record of food use is therefore not evidence that the untreated plant is safe.

References

  1. Kulinowski L, Luca SV, Minceva M, Skalicka-Wozniak K. A review on the ethnobotany, phytochemistry, pharmacology and toxicology of butterbur species (Petasites L.) . Journal of Ethnopharmacology (2022) [DOI]
  2. Kitajima M, Okabe K, Yoshida M, Nakabayashi R, Saito K, Kogure N, Takayama H. New otonecine-type pyrrolizidine alkaloid from Petasites japonicus . Journal of Natural Medicines (2019) [DOI]
  3. Niwa H, Ishiwata H, Yamada K. Separation and determination of macrocyclic pyrrolizidine alkaloids of the otonecine type present in the edible plant Petasites japonicus by reversed-phase high-performance liquid chromatography . Journal of Chromatography A (1983) [DOI]
  4. Takenaka M, Miyake N, Kimura T, Todoriki S, Urushiyama T. Reduction of pyrrolizidine alkaloids by cooking pre-treatment for the petioles and the young spikes of Petasites japonicus . Food Science and Technology Research (2022) [DOI]
  5. Anderson N, Borlak J. Hepatobiliary Events in Migraine Therapy with Herbs-The Case of Petadolex, A Petasites Hybridus Extract . Journal of Clinical Medicine (2019) [DOI]
  6. Agosti R, Duke RK, Chrubasik JE, Chrubasik S. Effectiveness of Petasites hybridus preparations in the prophylaxis of migraine: A systematic review . Phytomedicine (2006) [DOI]
  7. Guo L, Li K, Cui ZW, Kang JS, Son BG, Choi YW. S-Petasin isolated from Petasites japonicus exerts anti-adipogenic activity in the 3T3-L1 cell line by inhibiting PPAR-γ pathway signaling . Food & Function (2019) [DOI]
  8. Hiemori-Kondo M. Antioxidant compounds of Petasites japonicus and their preventive effects in chronic diseases: a review . Journal of Clinical Biochemistry and Nutrition (2020) [DOI]

This information is for educational purposes only and is not intended to replace professional medical advice. Always consult a qualified healthcare provider before using any herbal remedy, especially if you are pregnant, nursing, or taking medications.

📝 Notes

Public notes from the community and your own private notes on Great butterbur.

No notes yet.

Log in or register to add your own notes.

Back to Herb Database